Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV
Journal
Journal of virus eradication
Journal Volume
8
Journal Issue
4
Pages
100308
Date Issued
2022
Author(s)
Pang, Man Wai
Li, Guei-Chi
Liu, Wen-Chun
Su, Yi-Ching
He, Pu-Chi
Lin, Chia-Yi
Yeh, Chih-Yu
Cheng, Yu-Chen
Yao, Yi
Chen, Yi-Ting
Wu, Pei-Ying
Chen, Ling-Ya
Luo, Yu-Zhen
Chang, Hsi-Yen
Abstract
A community COVID-19 outbreak caused by the B.1.1.7 SARS-CoV-2 variant occurred in Taiwan in May 2021. High-risk populations such as people living with HIV (PLWH) were recommended to receive two doses of COVID-19 vaccines. While SARS-CoV-2 vaccines have demonstrated promising results in general population, real-world information on the serological responses remains limited among PLWH.
Subjects
Antibody; BNT162b2 vaccine; ChAdOx1 nCoV-19 (AZD1222) vaccine; Humoral immunity; mRNA-1273 vaccine
Publisher
MEDISCRIPT LTD
Type
journal article